Trial intelligence / Profile preview

Sildenafil for Liver Fibrosis After Fontan Operation

NCT04908657Phase 4Unknown

Sponsor
National Taiwan University Hospital
Start
Jul 2017
Primary completion
Jul 2023
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of ASP-001 in Liver Fibrosis (LF), sponsored by National Taiwan University Hospital. Status: unknown.

02

Drugs

ASP-001
03

Conditions

Liver Fibrosis (LF)

Beyond the preview

Go deeper on NCT04908657.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04908657.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call